granted
on 06 Feb 2024
Last Applicant/ Owned by
Chivers Way, Histon
Cambridge
GB
CB249BZ
Serial Number
90322057 filed on 16th Nov 2020
Registration Number
N/A
Correspondent Address
Michael T. Olsen
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel dRead More
pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; pure extracts of medicinal plants and herbs for medical purposes; dietetic foodstuffs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes
No 90322057
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 06th Feb 2024 | SOU EXTENSION 5 GRANTED |
| 05th Feb 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
| 18th Jan 2024 | SOU EXTENSION 5 FILED |
| 14th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
| 12th Jul 2023 | SOU EXTENSION 4 FILED |
| 12th Jul 2023 | SOU EXTENSION 4 GRANTED |
| 11th Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Feb 2023 | SOU TEAS EXTENSION RECEIVED |
